Insufficient scRNA-seq data for expression of CHIA at single-cell level.
Insufficient scRNA-seq data for expression of CHIA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 77% | 28.10 | 503 / 653 | 37% | 1.11 | 221 / 605 |
lung | 78% | 268.20 | 449 / 578 | 30% | 3.88 | 351 / 1155 |
stomach | 84% | 11969.40 | 300 / 359 | 2% | 0.09 | 7 / 286 |
adipose | 23% | 19.95 | 274 / 1204 | 0% | 0 | 0 / 0 |
kidney | 20% | 4.21 | 18 / 89 | 2% | 0.06 | 18 / 901 |
breast | 10% | 5.86 | 47 / 459 | 1% | 0.05 | 13 / 1118 |
liver | 10% | 2.36 | 22 / 226 | 1% | 0.03 | 4 / 406 |
peripheral blood | 10% | 3.67 | 90 / 929 | 0% | 0 | 0 / 0 |
uterus | 6% | 1.75 | 11 / 170 | 1% | 0.03 | 6 / 459 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.11 | 2 / 29 |
adrenal gland | 6% | 2.45 | 16 / 258 | 0% | 0 | 0 / 230 |
esophagus | 3% | 55.85 | 49 / 1445 | 3% | 3.13 | 5 / 183 |
spleen | 5% | 0.85 | 13 / 241 | 0% | 0 | 0 / 0 |
ovary | 4% | 2.11 | 7 / 180 | 1% | 0.04 | 4 / 430 |
bladder | 0% | 0 | 0 / 21 | 5% | 0.40 | 23 / 504 |
intestine | 3% | 0.50 | 29 / 966 | 2% | 2.52 | 8 / 527 |
heart | 4% | 1.98 | 35 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 3% | 0.94 | 45 / 1335 | 0% | 0 | 0 / 0 |
skin | 3% | 0.77 | 49 / 1809 | 0% | 0.00 | 1 / 472 |
prostate | 3% | 0.82 | 7 / 245 | 0% | 0 | 0 / 502 |
pancreas | 1% | 0.18 | 4 / 328 | 1% | 0.02 | 2 / 178 |
brain | 2% | 0.29 | 45 / 2642 | 0% | 0.01 | 2 / 705 |
muscle | 2% | 0.27 | 14 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006030 | Biological process | chitin metabolic process |
GO_0006915 | Biological process | apoptotic process |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0002376 | Biological process | immune system process |
GO_0002532 | Biological process | production of molecular mediator involved in inflammatory response |
GO_0000272 | Biological process | polysaccharide catabolic process |
GO_0006032 | Biological process | chitin catabolic process |
GO_0044245 | Biological process | polysaccharide digestion |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0019900 | Molecular function | kinase binding |
GO_0005515 | Molecular function | protein binding |
GO_0004568 | Molecular function | chitinase activity |
GO_0008061 | Molecular function | chitin binding |
Gene name | CHIA |
Protein name | Chitinase acidic Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Lung-specific protein TSA1902) chitinase (EC 3.2.1.14) |
Synonyms | |
Description | FUNCTION: Degrades chitin and chitotriose. May participate in the defense against nematodes, fungi and other pathogens. Plays a role in T-helper cell type 2 (Th2) immune response. Contributes to the response to IL-13 and inflammation in response to IL-13. Stimulates chemokine production by pulmonary epithelial cells. Protects lung epithelial cells against apoptosis and promotes phosphorylation of AKT1. Its function in the inflammatory response and in protecting cells against apoptosis is inhibited by allosamidin, suggesting that the function of this protein depends on carbohydrate binding. . |
Accessions | ENST00000430615.1 [Q9BZP6-2] ENST00000422815.5 ENST00000451398.6 [Q9BZP6-3] E9PLJ2 ENST00000483391.5 [Q9BZP6-3] A5D6V7 ENST00000352594.10 ENST00000489524.5 Q5VUV5 H7BXH6 ENST00000353665.10 [Q9BZP6-3] ENST00000343320.10 [Q9BZP6-1] Q9BZP6 ENST00000369740.6 [Q9BZP6-1] |